{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:40:35Z","timestamp":1790728835835,"version":"4.1.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00259-024-06619-8","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T09:02:21Z","timestamp":1706518941000},"page":"2151-2153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Alzheimer\u2019s disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era"],"prefix":"10.1007","volume":"51","author":[{"given":"Luca","family":"Sofia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7833-6095","authenticated-orcid":false,"given":"Silvia","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"6619_CR1","doi-asserted-by":"publisher","unstructured":"Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, Dickerson BC, Vandenberghe R, Ahmed S, Bak TH, Boeve BF, Butler C, Cappa SF, Ceccaldi M, de Souza LC, Dubois B, Felician O, Galasko D, Graff-Radford J, Graff-Radford NR, Hof PR, Krolak-Salmon P, Lehmann M, Magnin E, Mendez MF, Nestor PJ, Onyike CU, Pelak VS, Pijnenburg Y, Primativo S, Rossor MN, Ryan NS, Scheltens P, Shakespeare TJ, Su\u00e1rez Gonz\u00e1lez A, Tang-Wai DF, Yong KXX, Carrillo M, Fox NC; Alzheimer\u2019s Association ISTAART Atypical Alzheimer\u2019s Disease and Associated Syndromes Professional Interest Area. Consensus classification of posterior cortical atrophy.13:870-884Alzheimers Dement. 2017;13:870\u2013884. \nhttps:\/\/doi.org\/10.1016\/j.jalz.2017.01.014.","DOI":"10.1016\/j.jalz.2017.01.014"},{"key":"6619_CR2","doi-asserted-by":"publisher","first-page":"e230173","DOI":"10.1148\/radiol.230173","volume":"308","author":"S Haller","year":"2023","unstructured":"Haller S, J\u00e4ger HR, Vernooij MW, Barkhof F. Neuroimaging in dementia: more than typical Alzheimer disease. Radiology. 2023;308:e230173. https:\/\/doi.org\/10.1148\/radiol.230173.","journal-title":"Radiology."},{"key":"6619_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2018.12.001","volume":"76","author":"F Massa","year":"2019","unstructured":"Massa F, Arnaldi D, De Cesari F, Girtler N, Brugnolo A, Grazzini M, Bauckneht M, Meli R, Morbelli S, Pardini M, Sambuceti G, De Carli F, Tiraboschi P, Nobili F. Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI. Neurobiol Aging. 2019;76:9\u201317. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.12.001.","journal-title":"Neurobiol Aging."},{"key":"6619_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-023-02631-8","volume":"146","author":"L VandeVrede","year":"2023","unstructured":"VandeVrede L, La Joie R, Horiki S, Mundada NS, Koestler M, Hwang JH, Ljubenkov PA, Rojas JC, Rabinovici GD, Boxer AL, Seeley WW. Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab. Acta Neuropathol. 2023;146:777\u201381. https:\/\/doi.org\/10.1007\/s00401-023-02631-8.","journal-title":"Acta Neuropathol."},{"key":"6619_CR5","doi-asserted-by":"publisher","unstructured":"Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez-Porcel F, Pilotto A, Wyman-Chick KA, Grothe MJ, Kane JPM, Taylor A, Rongve A, Scholz S, Leverenz JB, Boeve BF, Aarsland D, McKeith IG, Lewis S, Leroi I, Taylor JP; ISTAART Lewy body dementias Trial Methods Working Group. Dementia with Lewy bodies: impact of co-pathologies and implications for clinical trial design. Alzheimers Dement. 2023;19:318-332. https:\/\/doi.org\/10.1002\/alz.12814.","DOI":"10.1002\/alz.12814"},{"key":"6619_CR6","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/brain\/awab099","volume":"144","author":"S Spina","year":"2021","unstructured":"Spina S, La Joie R, Petersen C, Nolan AL, Cuevas D, Cosme C, Hepker M, Hwang JH, Miller ZA, Huang EJ, Karydas AM, Grant H, Boxer AL, Gorno-Tempini ML, Rosen HJ, Kramer JH, Miller BL, Seeley WW, Rabinovici GD, Grinberg LT. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease. Brain. 2021;144:2186\u201398. https:\/\/doi.org\/10.1093\/brain\/awab099.","journal-title":"Brain."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06619-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06619-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06619-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:03:04Z","timestamp":1717063384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06619-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["6619"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06619-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"24 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SM received speaker honoraria from G.E. Healthcare and Life Molecular Imaging and honoraria for participation in advisory boards from Eli-Lilly. MB has received speaker honoraria from G.E. Healthcare. MP received research support from Novartis and Nutricia, and received fees from Novartis, Merck, and Biogen. DA received fees from Fidia, Jazz, and Lundbeck for lectures, consultation, and board participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"For related content on neuroimaging for Alzheimer\u2019s disease, please visit: .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Open access"}}]}}